1.Immunomodulators Extracted from Korean - style Fermented Soybean Paste and Their Function . 1 . Isolation of B Cell Mitogen from Korean - style Fermented Soybean Paste.
Bong Ki LEE ; Yun Soo JANG ; Sook Yi YI ; Kun Sub CHUNG ; Shin Yang CHOI
Korean Journal of Immunology 1997;19(4):559-570
Responses of mouse lymphocytes to the soybean paste fermented by Korean traditional fashion was examined to clarify its effects in cytokine production in vitro. A fraction of the soybean paste (KFSP-100) was prepared by precipitation with ammonium sulfate and by filtration through ultrafiltration membrane. KFSP-100 were added into cultures of fresh mouse splenic cells in vitro. KFSP-100 significantly enhanced the amount of IL-6 and TNF-a produced by macrophages and IL-6 and IFN-r produced by lymphocytes. Production of IL-12 by macrophages was not much affected by KFSP-100 treatments. The most noticeable finding was the fact that lymphocytes treated with KFSP-100 proliferated to an exceeding numbers (more than 10 times to the control) in 72 hours. The KFSP-100-induced proliferative response was specific to B cells since almost all of the KFSP-100-induced cells in the cultures of splenic cells were B cells. Furthermore, such a proliferative responses were equally observed only in cultures of purified B cells but not in cultures of T cells. In thermostability test, the biologically active components of the KFSP-100 is assumed to be either linear protein or glycoprotein. KFSP-100 did not induce agglutination of lymphocytes demonstrated by lectins in the same cells. These observations suggest that KFSP-100 may be a novel mitogen for B lymphocytes. The component (s) responsible for the B cell proliferation in KFSP-100 might be a factor gained by natural fermentation. None of the fractions of not fermented soybean paste prepared by the same methods demonstrate the same effect.
Agglutination
;
Ammonium Sulfate
;
Animals
;
B-Lymphocytes
;
Cell Proliferation
;
Fermentation
;
Filtration
;
Glycoproteins
;
Immunologic Factors*
;
Interleukin-12
;
Interleukin-6
;
Lectins
;
Lymphocytes
;
Macrophages
;
Membranes
;
Mice
;
Soybeans*
;
T-Lymphocytes
;
Ultrafiltration
2.Comparison of Distribution of Fibronectin and Fibrinogen in Placenta between Normotensive and Preeclamptic Pregnancies.
Dae Young CHUNG ; Jong Kun LEE ; Jong Chul SHIN ; Chong Seong YI ; Young LEE ; Eun Jung BAIK ; Chang Yi KIM ; Su Pyung KIM ; Woon Sub HAN
Korean Journal of Obstetrics and Gynecology 1998;41(12):2947-2951
In order to find out the distribution of fibronectin and fibrinogen in placenta among pregnancy induced hypertensive (PIH) patients, 6 normotensive pregnancies and 17 PIH patients were chosen. The placentas were obtained right after delivery and soaked in the 10% formalin solution. The score was measured in terms of the positiveness of the stain in immunohistochemical stain by using I antibody with the rabbit antihuman fibronectin and the rabbit anti-human fibrinogen. Comparison between two groups are as following: 1.The placenta of PIH patients showed significantly reduced positiveness of fibronectin in their fetal villous vessels and villous stroma. 2. In the PIH patients, the positiveness was reduced in the group giving the birth to intrauterine fetal growth retardation compared to giving birth to normal baby. 3. In both normotensive and PIH patients, the villous basement membrane did not show the staining response to fibronectin, while showing heavy staining response to fibrinogen. 4. The positiveness of fibrinogen in fetal vessels, villous basement membrane, intervillous space and stroma were almost same in both normotensive and PIH patients. From above results, we can conclude that there is abnormality in the distribution of fibronectin especially in the fetal vessels and the villous stroma of placenta among PIH patients. The cause of this result needs further study.
Basement Membrane
;
Fetal Growth Retardation
;
Fibrinogen*
;
Fibronectins*
;
Formaldehyde
;
Humans
;
Parturition
;
Placenta*
;
Pre-Eclampsia
;
Pregnancy*
3.The Preoperative Prognostic Factors for Outcome After LASEK Using the MEL60.
Jae Ryun KIM ; Jung Sub KIM ; Eun Jung JUN ; Hyun Seung KIM ; Sung Kun CHUNG
Journal of the Korean Ophthalmological Society 2010;51(8):1064-1070
PURPOSE: To investigate the preoperative clinical factors affecting the refractive outcome after laser-assisted subepithelial keratomileusis (LASEK). METHODS: This retrospective study was conducted on 58 patients (116 eyes) who underwent bilateral LASEK using the MEL60. The outcome efficacy and predictability of LASEK was examined by analyzing data including age, gender, preoperative uncorrected visual acuity, preoperative refraction (spherical equivalent and cylindrical diopter), central corneal thickness, tear breakup time, and Schirmer test through multiple logistic regression analysis. RESULTS: The preoperative factor associated with postoperative uncorrected visual acuity was the amount of preoperative spherical equivalent. Greater preoperative spherical equivalent was associated with decreased efficacy. Predictability was also associated with the amount of preoperative spherical equivalent. Greater preoperative spherical equivalent was associated with decreased predictability. The other preoperative factors including sex, age, preoperative uncorrected visual acuity, amount of preoperative cylinder diopter, intraocular pressure, tear breakup time, Schirmer test and central corneal thickness did not show any association with efficacy or predictability. CONCLUSIONS: The preoperative spherical equivalent was determined as the most important prognosis factor in LASEK, as it is in PRK or LASIK.
Humans
;
Intraocular Pressure
;
Keratectomy, Subepithelial, Laser-Assisted
;
Keratomileusis, Laser In Situ
;
Logistic Models
;
Prognosis
;
Retrospective Studies
;
Visual Acuity
4.Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
Jeongshim LEE ; Jee Suk CHANG ; Mi Ryung ROH ; Minkyu JUNG ; Choong-Kun LEE ; Byung Ho OH ; Kee Yang CHUNG ; Woong Sub KOOM ; Sang Joon SHIN
Cancer Research and Treatment 2020;52(3):730-738
Purpose:
We investigated the clinical efficacy of immune checkpoint blocker (ICB) therapy for metastatic or advanced melanoma in Korean patients. As well, we assessed whether the effects of ICBs can be enhanced by combination therapy with palliative radiotherapy (RT).
Materials and Methods:
We retrospectively reviewed the records of 127 patients with metastatic melanoma who received ICB with or without palliative RT between 2014 and 2018. The melanoma subtypes were classified as follows: chronic sun-damaged (CSD), acral, mucosal, and uveal. The primary endpoint was the objective response rate (ORR).
Results:
The overall ORR was 15%, with 11 complete and eight partial responses. ORRs for CSD, acral/mucosal, and uveal melanomas were 50%, 16.5%, and 0%, respectively (p=0.009). In addition to the subtype, stage at treatment, total tumor burden at treatment, and ICB type were significantly associated with ORR (all p < 0.05). Palliative RT was administered in 44% of patients during the treatment, and it did not affect ORR. Clinical responders to ICB therapy exhibited significantly higher 1-year progression-free and overall survival rates than nonresponders.
Conclusion
ORR for ICB monotherapy in Korean patients with melanoma is relatively modest compared with that in Western patients because the non-CSD subtypes are predominant in the Korean population. Our findings regarding combination therapy with ICB provided a rationale for the initiation of our phase II study (NCT04017897).